For Providers

What Is Anchor?

The Anal Cancer HSIL Outcomes Research study is a National Institutes of Health (NIH)-funded study with the primary objective of determining whether treating anal high-grade squamous intraepithelial lesions (HSIL) is effective in reducing the incidence of anal cancer in people living with HIV, just as screening for and treatment of similar lesions in the cervix reduces the incidence of cervical cancer.